Excellence in Hemoglobinopathies Research Award Program

by: Michael Saunders

The National Institutes of Health, more commonly known as the NIH, is a federal government agency operating within the United States Department of Health and Human Services that is appropriately responsible for supporting the nation's biomedical and health-related research studies.

The programs and grants of the NIH are specifically tailored to help in the achievement of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

Initially, the NIH and the NHLBI will enter into a five-year cooperative agreement with the most compelling applicant who has submitted a research proposal that could potentially develop therapeutic molecules, biomarkers, or imaging modalities in the field of hemoglobinopathies.

  (continued...)

Excellence in Hemoglobinopathies Research Award Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Health Care Innovation Challenge
The Centers for Medicare and & Medicaid Services has recently established the Health Care Innovation Challenge in an attempt to solicit proposals to establish interesting new models of service delivery that can potentially deliver the three-part aim of better health, better health care, and finally, lower costs through the improved quality of Medicare, Medicaid, and Children's Health Insurance Program.

---

Peer Reviewed Cancer Career Development Award Program
In keeping with this mission, the Department of the Army has established the Peer Reviewed Cancer Career Development Award Program in an attempt to stimulate the next generation of cancer research studies by providing new and early career investigator opportunities that would lead to innovative, cutting-edge research developments for the prevention, early detection, and treatment of cancer.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---